Skip to content

Comparison of live birth rates between GnRHa-HRT and HRT protocols for endometrium preparation in frozen embryo transfer cycles among couples with recurrent implantation failure: a multicenter, randomized controlled clinical trial

Comparison of live birth rates between GnRHa-HRT and HRT protocols for endometrium preparation in frozen embryo transfer cycles among couples with recurrent implantation failure: a multicenter, randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100242
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

GnRHa-HRT Group:GnRHa-HRT protocol
Frozen-thawed single blastocyst transfer
HRT Group:HRT protocol

Sponsors

Hospital Reproductive Medicine Affiliated to ShanDong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 38 Years

Inclusion criteria

Inclusion criteria: 1.Women with a history of RIF, RIF refers to failure to achieve a clinical pregnancy after one of the following conditions with all embryos transferred being of good quality: 3 or more embryo transfer cycles; 2 embryo transfer cycles where no less than three embryos were transferred cumulatively. 2.Women with at least 1 good-quality blastocysts on day 5 or day 6 of embryo for frozen-thawed single blastocyst transfer in IVF/ICSI cycles. 3.Women under the age of 38 years at oocyte retrieval. 4.Women with signed informed consents.

Exclusion criteria

Exclusion criteria: 1.Women with known uterine or endometrial pathologies, such as uterine malformation, intrauterine adhesions, hydrosalpinx, endometriosis, or adenomyosis. 2.Women with cycle cancellation due to thin endometrium (<7 mm) during the endometrium preparation process in previous frozen embryo transfer cycles. 3.Women with infectious diseases, autoimmune diseases and metabolic diseases, which were known to cause implantation failure. 4.Women with =2 previous miscarriages. 5.Women who use donated oocytes or sperm to achieve pregnancy, or transfer embryo after multiple vitrification-warming procedures. 6.Women with contraindications for the use of estrogen and progesterone drugs, such as history of breast cancer, risk of thrombosis, etc. 7.Women with medical contraindications to assisted reproductive technology and/or pregnancy.

Design outcomes

Primary

MeasureTime frame
Live birth rate;

Secondary

MeasureTime frame
Clinical pregnancy loss rate;Clinical pregnancy rate;Onging pregnancy rate;Biochemical pregnancy loss rate;Birth weight;Good live birth rate;Biochemical pregnancy rate;Maternal complication rate;Neonatal complication rate;

Countries

China

Contacts

Public ContactQian Zhang

Hospital Reproductive Medicine Affiliated to ShanDong University

zhangqian2018@sduivf.com+86 531 85651172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026